Enantia at ChemOutsourcing 2026

Enantia will be attending ChemOutsourcing from September 15–17, and we’re looking forward to meeting companies working on challenging small-molecule and peptide programs.

At Enantia, we provide end-to-end chemical R&D support for small molecules, from medicinal chemistry and route scouting to process development, optimization, and API manufacturing. We help our partners tackle challenging synthetic problems and develop efficient, scalable processes adapted to their development needs.

Beyond synthetic chemistry, our solid-state R&D expertise covers polymorph, salt, and cocrystal screening, solid-form selection, and crystallization development, helping address challenges related to solubility, stability, manufacturability, and IP. We also support peptide crystallization, applying our solid-state expertise to the development and optimization of peptide products.

By bringing synthetic chemistry and solid-state development capabilities together under one roof, Enantia can support projects across multiple stages of chemical development with a highly integrated approach.

📩 If you’re attending ChemOutsourcing and would like to discuss a current or upcoming chemistry program, we’d be happy to meet in Boston.